Molecular epidemiology of rotavirus in the era of vaccination

Research output: Contribution to journalReview ArticleOtherpeer-review


Rotavirus is the principal aetiological agent of severe acute gastroenteritis in young children worldwide. Two vaccines, Rotarix [GlaxoSmithKline] and RotaTeq [Merck], have been developed to address the large burden of disease experienced worldwide. Both vaccines have been successful in decreasing morbidity and mortality associated with rotavirus gastroenteritis. Minor fluctuations in rotavirus epidemiology have been observed since vaccine introduction. However, it is unclear whether these observations are due to selection pressures specific to vaccine introduction or due to natural genotype fluctuations.
Original languageEnglish
Pages (from-to)64-66
Number of pages3
JournalMicrobiology Australia
Issue number2
Publication statusPublished - 2012
Externally publishedYes

Cite this